RAINBOW1,462.00

Rainbow Childrens Medicare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISKIMSPOLYMEDPFIZERONESOURCEJUBLPHARMAVIJAYAMcap ₹14,848 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.740.740.790.78
Interest Burden (Pretax/EBIT) ×0.930.940.910.89
EBIT Margin %24.4323.1823.1122.89
Asset Turnover ×0.600.640.610.61
Financial Leverage (Assets/Equity) ×1.721.611.671.67
ROE (5-step product) %17.3316.6216.8216.23
ROE (reported, avg-equity basis) %17.1616.5016.7316.73
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.